225 related articles for article (PubMed ID: 12449273)
21. Aspirin in the prevention of cardiovascular disease in women.
Schwartz DJ
N Engl J Med; 2005 Jun; 352(26):2751-2; author reply 2751-2. PubMed ID: 15987927
[No Abstract] [Full Text] [Related]
22. New daily aspirin guidelines address age, sex differences.
Mayo Clin Womens Healthsource; 2009 Sep; 13(9):3. PubMed ID: 19652638
[No Abstract] [Full Text] [Related]
23. [Antiplatelet drugs in prevention and treatment of coronary heart disease: aspirin is obligatory, quite sufficient, and safe].
Averkov OV
Kardiologiia; 2003; 43(6):77-83. PubMed ID: 13677327
[No Abstract] [Full Text] [Related]
24. Aspirin for primary prevention. Doctors and patients should understand potential benefits and risks of aspirin treatment.
Alkhenizan A
BMJ; 2000 Dec; 321(7274):1472-3. PubMed ID: 11187951
[No Abstract] [Full Text] [Related]
25. [Female, young, healthy. ASS does not protect from myocardial infarct].
MMW Fortschr Med; 2005 Mar; 147(12):10. PubMed ID: 15832782
[No Abstract] [Full Text] [Related]
26. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
Toth PP
Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
[TBL] [Abstract][Full Text] [Related]
27. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
28. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Anselmino M; Malmberg K; Ohrvik J; Rydén L;
Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
[TBL] [Abstract][Full Text] [Related]
29. [Acetylsalicylic acid does not prevent cardiovascular disease. Poor scientific support for therapeutic guidelines according to primary prevention studies].
Mooe T
Lakartidningen; 2006 Sep 20-26; 103(38):2732-6. PubMed ID: 17058766
[No Abstract] [Full Text] [Related]
30. Aspirin in the primary prevention of vascular disease.
Cleland JG
Lancet; 2009 Sep; 374(9693):878; author reply 879. PubMed ID: 19748392
[No Abstract] [Full Text] [Related]
31. Appropriate aspirin use for primary prevention of cardiovascular disease.
Miser WF
Am Fam Physician; 2011 Jun; 83(12):1380-6. PubMed ID: 21671538
[No Abstract] [Full Text] [Related]
32. Clopidogrel but not Aspirin prevents acute smoking-induced platelet aggregation in patients with stable coronary artery disease.
Addad F; Chakroune T; Asma A; Abderazek F; Zohra D; Ghrissi I; Hassine M; Gamra H; Elalamy I
Thromb Res; 2009 Feb; 123(4):640-3. PubMed ID: 18602138
[No Abstract] [Full Text] [Related]
33. Aspirin for primary prevention of myocardial infarction: what is the evidence?
Kappagoda T; Amsterdam E
J Cardiopulm Rehabil Prev; 2012; 32(1):1-8. PubMed ID: 21946421
[TBL] [Abstract][Full Text] [Related]
34. [Thrombolytic therapy of ischemic heart disease].
Ishikawa K
Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1621-4. PubMed ID: 9410971
[No Abstract] [Full Text] [Related]
35. [Aspirin for primary prevention of cardiovascular diseases].
Li XY
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):889-91. PubMed ID: 16029526
[No Abstract] [Full Text] [Related]
36. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
[TBL] [Abstract][Full Text] [Related]
37. [Non-cardiac surgery in patients with previous percutaneous coronary intervention according to the 2014 European guidelines].
Rollini F; Franchi F; Angiolillo DJ
G Ital Cardiol (Rome); 2015 May; 16(5):277-80. PubMed ID: 25994462
[No Abstract] [Full Text] [Related]
38. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.
Faraday N; Becker DM; Yanek LR; Herrera-Galeano JE; Segal JB; Moy TF; Bray PF; Becker LC
Am J Cardiol; 2006 Sep; 98(6):774-9. PubMed ID: 16950183
[TBL] [Abstract][Full Text] [Related]
39. [The role of aspirin in the primary prevention of cardiovascular disease].
Rodondi N; Cornuz J
Rev Med Suisse; 2006 Mar; 2(56):646-51. PubMed ID: 16597054
[TBL] [Abstract][Full Text] [Related]
40. [Patients with arterial occlusive disease die of myocardial infarct or stroke. The dangerous sisters: arterial occlusive disease and coronary heart disease].
MMW Fortschr Med; 2004; 146 Suppl 1():6-7. PubMed ID: 15493409
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
